TheraRadar
← Back
Data updated: Mar 29, 2026

HEATHER

CardiovascularGastroenterologyInfectious Disease
Generics

HEATHER is a generic drug manufacturer focused on Cardiovascular, Gastroenterology, Infectious Disease.

1974
Since
18
Drugs
-
Trials
219
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DOXYCYCLINE HYCLATE 2026-02-19
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 32%
1 drugs
Gastroenterology 32%
1 drugs
Infectious Disease 32%
1 drugs
Oncology 5%
0 drugs Phase 1: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Gastroenterology
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular
Baxter specialty
Infectious Disease, Cardiovascular, Oncology
Johnson & Johnson big-pharma
Oncology, Infectious Disease, Cardiovascular
WAYLIS THERAP big-pharma
Oncology, Cardiovascular, Infectious Disease, Gastroenterology